Flagship Ventures Fund V General Partner LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Flagship Ventures Fund V General Partner LLC
CIK #0001724575
Sector Form 13F Holdings Value ($B)
Moderna Inc 0.1
SANA Biotechnology Inc 0.1
Foghorn Therapeutics Inc 0.1
Seres Therapeutics Inc 0.0
 
 
 
 
 
 
 
Holdings by Sector ($B)
10.08.06.04.02.00.02014201820222027
EDGAR Form CIK 2011 - 2026
13F-NT [0001724575]
3 [0001724575]
4 [0001724575]
Form 3/4/5 Subject 2011 - 2026
Flagship Ventures Fund V LP
Flagship Ventures Opportunities Fund I LP
Flagship Pioneering Special Opportunities Fund II General Pa
Flagship Pioneering Special Opportunities Fund II LP
Flagship Ventures Fund V General Partner LLC
Flagship Pioneering Fund VII LP
Flagship Pioneering LLC
Foghorn Therapeutics Inc
Flagship Ventures Opportunities Fund I General Partner LLC
Afeyan Noubar
Flagship Pioneering Fund VII General Partner LLC
Flagship VentureLabs V Manager LLC
Sana Biotechnology Inc
Flagship V VentureLabs Rx Fund LP
Flagship Pioneering Fund VI General Partner LLC
Flagship Pioneering Fund VI LP
Flagship VentureLabs V LLC
Sigilon Therapeutics Inc
Codiak BioSciences Inc
Omega Therapeutics Inc
Flagship Ventures Fund IV LP
Rubius Therapeutics Inc
Flagship Ventures Fund IV General Partner LLC
Nutritional Health Side Fund LP
Kaleido Biosciences Inc
Nutritional Health Disruptive Innovation Fund LP
Evelo Biosciences Inc
Kania Edwin
Denali Therapeutics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Foghorn Therapeutics Inc FHTX
Series 1 Warrants to purchase Common Stock · derivative
2026-01-13 Grant 1,117,734
Foghorn Therapeutics Inc FHTX
Pre-Funded Warrants to purchase Common Stock · derivative
2026-01-13 Grant 2,235,468 $6.71 14,999,990
Foghorn Therapeutics Inc FHTX
Series 2 Warrants to purchase Common Stock · derivative
2026-01-13 Grant 1,117,734
Sana Biotechnology Inc SANA
Common Stock
2023-09-13 Other 1,181,745
Sana Biotechnology Inc SANA
Common Stock
2023-09-13 Other 4,926,378
Sana Biotechnology Inc SANA
Common Stock
2023-09-13 Other 2,825,989
Sana Biotechnology Inc SANA
Common Stock
2023-09-13 Other 70,813
Sana Biotechnology Inc SANA
Common Stock
2023-09-13 Other 345,069
Sana Biotechnology Inc SANA
Common Stock
2023-09-13 Other 2,431,281
Sigilon Therapeutics Inc SGTX
Common Stock
2023-08-11 Tender 683,760 $14.92 10,201,699
Sigilon Therapeutics Inc SGTX
Common Stock
2023-08-11 Tender 113,960 $14.92 1,700,283
Sana Biotechnology Inc SANA
Common Stock
2023-06-07 Sell 177,240 $6.24 1,105,978
Sana Biotechnology Inc SANA
Common Stock
2023-06-07 Sell 22,760 $6.24 142,022
Sana Biotechnology Inc SANA
Common Stock
2023-06-06 Sell 22,297 $6.31 140,694
Sana Biotechnology Inc SANA
Common Stock
2023-06-06 Sell 181,461 $6.31 1,145,019
Sana Biotechnology Inc SANA
Common Stock
2023-05-26 Sell 72,670 $6.23 452,734
Sana Biotechnology Inc SANA
Common Stock
2023-05-26 Sell 9,330 $6.23 58,126
Sana Biotechnology Inc SANA
Common Stock
2023-05-25 Sell 102,245 $6.35 649,256
Sana Biotechnology Inc SANA
Common Stock
2023-05-25 Sell 13,127 $6.35 83,356
Sana Biotechnology Inc SANA
Common Stock
2023-05-24 Sell 39,580 $6.57 260,041
showing 20 of 121 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com